These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 5504560)

  • 21. [Trans-cerebral electrophoresis of L-DOPA in the complex treatment of parkinsonism].
    Neĭmark EZ; Evtushenko SK; Dukhovnaia MA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1334-8. PubMed ID: 6506979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term treatment of Parkinsonism with L-dopa.
    Presthus J; Holmsen R
    Acta Neurol Scand Suppl; 1972; 51():131-2. PubMed ID: 4514340
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of the Parkinson syndrome with amantadine].
    Hartmann-von Monakow K
    Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
    [No Abstract]   [Full Text] [Related]  

  • 24. [The treatment of Parkinson's syndrome with L-dopa].
    Völler GW; Kerstan J
    Nervenarzt; 1970 Mar; 41(3):138-44. PubMed ID: 5447886
    [No Abstract]   [Full Text] [Related]  

  • 25. L-dopa for postencephalitic Parkinsonism.
    Krasner N; Cornelius JM
    Br Med J; 1970 Nov; 4(5733):496. PubMed ID: 5481239
    [No Abstract]   [Full Text] [Related]  

  • 26. Side effects of L-dopa treatment.
    Greenburg J
    Pa Med; 1971 Apr; 74(4):55-6. PubMed ID: 5147645
    [No Abstract]   [Full Text] [Related]  

  • 27. [The Rorschach test in parkinsonian patients. Its course during treatment with L dopa. Its prognostic value].
    Sevilla M; Vernet JP; Becle J; Darcourt G
    Ann Med Psychol (Paris); 1973 May; 1(5):577-608. PubMed ID: 4761931
    [No Abstract]   [Full Text] [Related]  

  • 28. Abnormal mouth-movements and oral damage associated with L-DOPA treatment.
    Sacks OW; Ross SJ; DePaola DP; Kohl MS
    Ann Dent; 1970; 29(4):130-44. PubMed ID: 5275661
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of parkinsonism with levodopa.
    Yahr MD; Duvoisin RC; Schear MJ; Barrett RE; Hoehn MM
    Arch Neurol; 1969 Oct; 21(4):343-54. PubMed ID: 5820999
    [No Abstract]   [Full Text] [Related]  

  • 30. [Long-term effects of amantadine in striatal syndromes].
    Rovetta P
    Minerva Med; 1971 Oct; 62(82):3965-7. PubMed ID: 5125054
    [No Abstract]   [Full Text] [Related]  

  • 31. [Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study].
    Tissot R; de Ajuriaguerra J
    Nouv Presse Med; 1973 Feb; 2(5):315-6. PubMed ID: 4686226
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of L-dopa and stereotaxic surgery in Parkinsonism].
    Sugita K; Mutsuga N; Takaoka Y; Takeda A
    No To Shinkei; 1970 Sep; 22(9):1103-8. PubMed ID: 4918927
    [No Abstract]   [Full Text] [Related]  

  • 33. L-dopa in idiopathic parkinsonism.
    Calne DB; Stern GM; Spiers AS; Laurence DR
    Lancet; 1969 Nov; 2(7628):973-6. PubMed ID: 4186975
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment with L-dopa in Parkinsonian syndromes].
    De Renzi E; Pieczuro A
    Sist Nerv; 1970; 22(1):1-11. PubMed ID: 5502951
    [No Abstract]   [Full Text] [Related]  

  • 35. Levodopa and amantadine in the treatment of Parkinsonism.
    Critchley E
    Practitioner; 1972 Apr; 208(246):499-504. PubMed ID: 5031037
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of Parkinson's disease with L-dopa. 77 cases].
    Boudin G; Castaigne P; Lhermitte F; Beck H; Guillard A; Marteau R; Pepin B; Rondot P; Raphy B
    Rev Neurol (Paris); 1970 Feb; 122(2):89-102. PubMed ID: 4931719
    [No Abstract]   [Full Text] [Related]  

  • 37. [Problems and therapy of L-DOPA-induced dyskinesias].
    Völler GW; Deze J; Gundlach U; Muschard F
    Nervenarzt; 1972 Nov; 43(11):584-6. PubMed ID: 4564994
    [No Abstract]   [Full Text] [Related]  

  • 38. Parkinsonism and dopa.
    N Z Med J; 1969 May; 69(444):306-7. PubMed ID: 5256210
    [No Abstract]   [Full Text] [Related]  

  • 39. [Combined treatment of Parkinsonism with levopa, midantan and anticholinergic drugs].
    Evtushenko SK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Dec; 76(12):1797-1802. PubMed ID: 1015115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Parkinson's disease with L-dopa: a current appraisal.
    Kofman O
    Can Med Assoc J; 1971 Mar; 104(6):483-7. PubMed ID: 5549988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.